(235 days)
Not Found
No
The 510(k) summary describes a mechanical interbody fusion device and its performance in mechanical testing. There is no mention of AI, ML, image processing, or any software-driven analytical capabilities.
Yes
The device is used for intervertebral body fusion procedures to treat degenerative disc disease, which involves medically addressing a health condition.
No
This device is an intervertebral body fusion device used for treatment, not diagnosis. It is an implant for surgical procedures, as indicated by its description as an "Anterior Lumbar Interbody Fusion (ALIF) System."
No
The device description clearly outlines a physical implantable device made of hardware components (fixation plate, end caps, bone screws) intended for surgical implantation. There is no mention of any software component.
No, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostics are medical devices used to perform tests on samples taken from the human body (like blood, urine, or tissue) to provide information about a person's health.
- Device Description and Intended Use: The description clearly states that the OPTIMUS Anterior Lumbar Interbody Fusion (ALIF) System is an implantable device used in surgical procedures to fuse vertebrae in the spine. It is a physical device inserted into the body, not a test performed on a sample outside the body.
The information provided describes a surgical implant, not a diagnostic test.
N/A
Intended Use / Indications for Use
The OPTIMUS Anterior Lumbar Interbody Fusion (ALIF) System is indicated for intervertebral body fusion procedures at one or two contiguous levels (L2-Sl) in skeletally mature patients with degenerative disc disease (DDD). DDD is defined as back pain of discogenic origin with degeneration of the disc confirmed by the history and radiographic studies. DDD patients may also have up to Grade I Spondylolisthesis or retrolisthesis at the involved levels. The patient should be skeletally mature and have had six months of non-operative treatment.
The OPTIMUS Anterior Lumbar Interbody Fusion (ALIF) System is a stand-alone system intended to be used with bone screws, autogenous bone graft and requires no additional supplementary fixations. One device is used per intervertebral space.
Product codes (comma separated list FDA assigned to the subject device)
OVD
Device Description
The Optimus Anterior Lumbar Interbody Fusion (ALIF) system is a zero profile stand-alone interbody that combines the benefits of an anterior fixation plate and fusion device. Optimus is a modular design that consists of a center fixation plate, lordotic end caps and three bone screws for anterior fixation and stability. The bone screws thread into the fixation plate and pass through the superior and inferior openings of the end caps to fixate the implant with the adjacent vertebral bodies. The device is available in two footprints, multiple heights, lordotic angles and screw lengths.
OPTIMUS: Device Characteristics
Footprint L x W (mm): 25 x 32, 29 x 36
Lordotic Angles (deg): 6, 10, 14
Heights (mm): 9-13 (Posterior)
Number of Bone Screws: 3
Bone Screw Diameter (mm): 5.0
Bone Screw Lengths: 24-32
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Lumbar spine (L2-S1)
Indicated Patient Age Range
Skeletally mature patients
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Testing was performed in accordance to the following standards:
- Static Compression as per ASTM F2077
- Static Compression Shear as per ASTM F2077
- Static Torsion as per ASTM F2077
- Dynamic Compression as per ASTM 2077
- Dynamic Compression Shear as per ASTM 2077
- Subsidence as per ASTM F2267
- Expulsion as per ASTM F04.25.02.02 (Draft standard)
The Optimus device demonstrated to be mechanically superior in static compression, static shear, and static torsion, compared to the previously cleared predicate devices (Pillar SA and Pathway AVID). Additionally, the Optimus device demonstrated to be mechanically equivalent in subsidence and expulsion, compared to the previously cleared predicate devices (Pillar SA and Pathway AVID)
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
K111726, K090566, K081849, K130445, K103369, K110632, K112036
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 888.3080 Intervertebral body fusion device.
(a)
Identification. An intervertebral body fusion device is an implanted single or multiple component spinal device made from a variety of materials, including titanium and polymers. The device is inserted into the intervertebral body space of the cervical or lumbosacral spine, and is intended for intervertebral body fusion.(b)
Classification. (1) Class II (special controls) for intervertebral body fusion devices that contain bone grafting material. The special control is the FDA guidance document entitled “Class II Special Controls Guidance Document: Intervertebral Body Fusion Device.” See § 888.1(e) for the availability of this guidance document.(2) Class III (premarket approval) for intervertebral body fusion devices that include any therapeutic biologic (e.g., bone morphogenic protein). Intervertebral body fusion devices that contain any therapeutic biologic require premarket approval.
(c)
Date premarket approval application (PMA) or notice of product development protocol (PDP) is required. Devices described in paragraph (b)(2) of this section shall have an approved PMA or a declared completed PDP in effect before being placed in commercial distribution.
0
APR 1 1 2014
510(k) Summay
Date Prepared
April 11th, 2014
Name of Firm
Custom Spine, Incorporated 9 Campus Drive Parsippany, NJ 07054 Phone: (973) 808-0019 Fax: (973) 808-0707
Official Correspondent
Hanaa Shahin Regulatory Affairs and Quality Assurance 9 Campus Drive Parsippany, NJ 07054 Phone: (973) 265-5042 Fax: (973) 770-7746 E-mail: hanaas@customspine.com
Establishment Number
3005129649
Device Name
Legally Marketed Trade Name: (Proposed) OPTIMUS Common Name: Lumbar stand-alone intervertebral body fusion device Device Classification: Class II Regulation Number: 21 CFR 888.3080 Device Product Codes: OVD
Predicate Devices
Custom Spine's Pathway AVID (K111726, K090566), Orthofix's Pillar SA (K081849), Spinal USA Vault (K130445, K103369), Spinal Elements Lucent (K110632), X-Spine's Calix (K112036)
1
Device Description
The Optimus Anterior Lumbar Interbody Fusion (ALIF) system is a zero profile stand-alone interbody that combines the benefits of an anterior fixation plate and fusion device. Optimus is a modular design that consists of a center fixation plate, lordotic end caps and three bone screws for anterior fixation and stability. The bone screws thread into the fixation plate and pass through the superior and inferior openings of the end caps to fixate the implant with the adjacent vertebral bodies. The device is available in two footprints, multiple heights, lordotic angles and screw lengths.
| OPTIMUS: Device Characteristics | |
|---|---|
| Footprint | |
| L x W (mm) | 25 x 32 |
| 29 x 36 | |
| Lordotic Angles (deg) | 6, 10, 14 |
| Heights (mm) | 9-13 (Posterior) |
| Number of Bone Screws | 3 |
| Bone Screw Diameter (mm) | 5.0 |
| Bone Screw Lengths | 24-32 |
Indications for Use
The OPTIMUS Anterior Lumbar Interbody Fusion (ALIF) System is indicated for intervertebral body fusion procedures at one or two contiguous levels (L2-Sl) in skeletally mature patients with degenerative disc disease (DDD). DDD is defined as back pain of discogenic origin with degeneration of the disc confirmed by the history and radiographic studies. DDD patients may also have up to Grade I Spondylolisthesis or retrolisthesis at the involved levels. The patient should be skeletally mature and have had six months of non-operative treatment.
The OPTIMUS Anterior Lumbar Interbody Fusion (ALIF) System is a stand-alone system intended to be used with bone screws, autogenous bone graft and requires no additional supplementary fixations. One device is used per intervertebral space.
2
Materials
The following materials are used in the Optimus system:
- Fixation Plates are manufactured from titanium (Ti-6Al-4V, ASTM F136) .
- . End Caps are manufactured from PEEK Optima LT1 (Polyetheretherketone, ASTM F2026) and titanium (Ti-6Al-4V, ASTM F136) and are coated with plasma sprayed CP-titanium (ASTM F1580)
- . Bone Screws are manufactured from titanium (Ti-6Al-4V, ASTM F136)
Performance Data
Testing was performed in accordance to the following standards:
- Static Compression as per ASTM F2077
- . Static Compression Shear as per ASTM F2077
- . Static Torsion as per ASTM F2077
- . Dynamic Compression as per ASTM 2077
- . Dynamic Compression Shear as per ASTM 2077
- Subsidence as per ASTM F2267
- . Expulsion as per ASTM F04.25.02.02 (Draft standard)
The Optimus device demonstrated to be mechanically superior in static compression, static shear, and static torsion, compared to the previously cleared predicate devices (Pillar SA and Pathway AVID). Additionally, the Optimus device demonstrated to be mechanically equivalent in subsidence and expulsion, compared to the previously cleared predicate devices (Pillar SA and Pathway AVID)
Substantial Equivalence Statement
Documentation is provided to demonstrate that the OPTIMUS Anterior Lumbar Interbody Fusion (ALIF) System is substantially equivalent to its predicate devices in terms of its material, design, indications for use, and performance characteristics.
3
DEPARTMENT OF HEALTH & HUMAN SERVICES
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
April 11, 2014
Custom Spine, Incorporated Ms. Hanaa Shahin Regulatory Affairs and Quality Assurance 9 Campus Drive Parsippany, New Jersey 07054
Re: K132596
Trade/Device Name: OPTIMUS Regulation Number: 21 CFR 888.3080 Regulation Name: Intervertebral body fusion device Regulatory Class: Class II Product Code: OVD Dated: March 6, 2014 Received: March 10, 2014
Dear Ms. Shahin:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent ffor the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set
4
Page 2 – Ms. Hanaa Shahin
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable. the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Small Manufacturers, International and Consumer Assistance at its tollfree number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/McdicalDevices/Safetv/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely yours.
Ronald-P. Jean -S for
- Mark N. Melkerson Director Division of Orthopedic Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
5
Section VI. INDICATIONS FOR USE STATEMENT
K132596 510(K) NUMBER: _______________________________________________________________________________________________________________________________________________________________
DEVICE NAME: _ _ _ _ _ OPTIMUS
Intended Use/Indications for Use
The OPTIMUS Anterior Lumbar Interbody Fusion (ALIF) System is indicated for intervertebral body fusion procedures at one or two contiguous levels (L2-SI) in skeletally mature patients with degenerative disc disease (DDD). DDD is defined as back pain of discogenic origin with degeneration of the disc confirmed by the history and radiographic studies. DDD patients may also have up to Grade I Spondylolisthesis or retrolisthesis at the involved levels. The patient should be skeletally mature and have had six months of non-operative treatment.
The OPTIMUS Anterior Lumbar Interbody Fusion (ALIF) System is a stand-alone system intended to be used with bone screws, autogenous bone graft, and requires no additional supplementary fixations. One device is used per intervertebral space.
Prescription Use × (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(Please DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
Concurrence of Center for Devices and Radiological Health (CDRH)
- Dmitriev
Division of Orthopedic Devices